These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25406899)

  • 1. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.
    Reddy S; Fung A; Manlhiot C; Tierney ES; Chung WK; Blume E; Kaufman BD; Goldmuntz E; Colan S; Mital S
    Pediatr Res; 2015 Feb; 77(2):363-9. PubMed ID: 25406899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
    Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
    J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
    Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
    Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
    Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
    Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy.
    Fiuzat M; Neely ML; Starr AZ; Kraus WE; Felker GM; Donahue M; Adams K; Piña IL; Whellan D; O'Connor CM
    Eur J Heart Fail; 2013 Mar; 15(3):258-66. PubMed ID: 23115322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.
    Nonen S; Okamoto H; Akino M; Matsui Y; Fujio Y; Yoshiyama M; Takemoto Y; Yoshikawa J; Azuma J; Kitabatake A
    Br J Clin Pharmacol; 2005 Oct; 60(4):414-7. PubMed ID: 16187973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
    Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
    Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
    Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
    Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker pharmacogenetics in heart failure.
    Shin J; Johnson JA
    Heart Fail Rev; 2010 May; 15(3):187-96. PubMed ID: 18437562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.
    Kardia SL; Kelly RJ; Keddache MA; Aronow BJ; Grabowski GA; Hahn HS; Case KL; Wagoner LE; Dorn GW; Liggett SB
    BMC Med Genet; 2008 Oct; 9():93. PubMed ID: 18947427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
    Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
    Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
    Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
    JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.